![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 4 of 4. This is the beginning of the thread.
Posted by jealibeanz on April 26, 2007, at 19:33:09
I found this on Medscape today:
http://www.medscape.com/viewarticle/555557
It talks about Saredutant, which apparently the author feels may appear in late 2007 or 2008.
I thought they had some negative trials with the drug in the past year. I'd be very surprised if it were that soon, even if it were approved. Manufacturing of the drug takes some time. Even the facilities and processing procedures have to undergo inspection.
At least he seems hopeful. The last article he wrote on pipeline AD's wasn't very inspiring. He seems to have changed his tune a bit.
Posted by JR Boudreaux on April 27, 2007, at 7:38:24
In reply to Interesting Article on Pipeline AD's, posted by jealibeanz on April 26, 2007, at 19:33:09
Thanks for the link. That's interesting.
Posted by jealibeanz on April 27, 2007, at 9:52:40
In reply to Re: Interesting Article on Pipeline AD's » jealibeanz, posted by JR Boudreaux on April 27, 2007, at 7:38:24
> Thanks for the link. That's interesting.
No problem... I hope it's accurate! It would be nice to have a new option.
Posted by jealibeanz on April 28, 2007, at 6:49:56
In reply to Re: Interesting Article on Pipeline AD's » JR Boudreaux, posted by jealibeanz on April 27, 2007, at 9:52:40
Has anyone been able to locate where it says on the FDA's website that certain trials have been completed? I don't know what page he was referencing. I'm surprised he didn't mention their other AD in the pipeline, the beta-3 antagonist, becuase I thought it was further ahead.
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.